A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Janssen Research & Development, LLC

ClinicalTrials.gov Identifier:

NCT01369329

First received: June 7, 2011

Last updated: July 1, 2015

Last verified: July 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2013
Primary Completion Date:	June 2013 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	May 7, 2014